Using liquid biopsies to test for ESR1 mutations in breast cancer is more feasible for patients and has quicker turnaround ...

Importance of Bio-Techne’s New Assay While ESR1 gene mutations are extremely rare in cancer patients before treatment, the use of endocrine therapies causes these mutations to emerge in as many ...

Seth Wander, MD, PhD, discusses the extended survival with elacestrant in a real-world, which was longer than the randomized phase 3 trial data.

However, vepdegestrant was not effective in a larger group of participants with breast cancer lacking the ESR1 mutation.

Around 70% of all metastatic breast cancer cases are HR-positive and HER2-negative, and ESR1 mutations are found in up to 40% of these tumours. That suggests there should be plenty of eligible ...

Piper Sandler lowered the firm’s price target on Arvinas (ARVN) to $24 from $67 on narrowed vepdegestrant ESR1-mutant mBC approval, while ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

The press release provides scant detail, highlighting two critical points: (1) the primary endpoint in the intention-to-treat [ITT] population, and (2) the primary endpoint in the ESR1-mutant ...

P1220-ESR1 supports High-Profile H.264 compression, a vast improvement in quality over MPEG-4 and 20 times more efficient than MJPEG. Pelco SD435-PG-E1-X true day / night external PTZ dome camera - ...